PMA supplement
P120023 S002: KAMRA INLAY
FDA PMA supplement · Normal 180 Day Track · Corneagen
Key facts
| Original PMA | P120023 |
|---|---|
| Supplement number | S002 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | KAMRA INLAY |
| Generic name | Implant, corneal, refractive |
| Applicant | Corneagen |
| Product code | LQE |
| Received date | Oct 28, 2015 |
| Decision date | Oct 7, 2016 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: